These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36196658)

  • 1. Acute myocardial injury as a sole presentation of COVID-19 in patient without cardiovascular risk factors.
    Filipiak-Strzecka D; Plewka M; Szymczyk E; Frynas-Jończyk K; Szymczyk K; Lipiec P; Kasprzak JD
    Cardiol J; 2022; 29(5):878-879. PubMed ID: 36196658
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection markedly increases long-term cardiovascular risk.
    Liuzzo G; Volpe M
    Eur Heart J; 2022 May; 43(20):1899-1900. PubMed ID: 35362024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial commentary: COVID-19 as a cardiovascular disease risk factor.
    Oktay AA; Suboc TM; Volgman AS
    Trends Cardiovasc Med; 2022 Nov; 32(8):476-478. PubMed ID: 35850405
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the COVID‑19 pandemic on blood pressure control and cardiovascular risk profile in patients with hypertension.
    Januszewicz A; Wojciechowska W; Prejbisz A; Dobrowolski P; Rajzer M; Kreutz R
    Pol Arch Intern Med; 2021 Oct; 131(10):. PubMed ID: 34704702
    [No Abstract]   [Full Text] [Related]  

  • 5. The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    Abbasi J
    JAMA; 2022 Mar; 327(12):1113-1114. PubMed ID: 35234824
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.
    Zhao YH; Zhao L; Yang XC; Wang P
    Rev Cardiovasc Med; 2021 Mar; 22(1):159-165. PubMed ID: 33792257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular disease.
    Otto CM
    Heart; 2021 Mar; 107(5):345-347. PubMed ID: 33574131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathophysiological basis and diagnosis of the cardiovascular system damage caused by coronavirus infection].
    Serezhina EK; Obrezan AG
    Kardiologiia; 2022 Mar; 62(3):82-88. PubMed ID: 35414365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Siniorakis E; Arvanitakis S; Katsianis A; Nikolopoulos I
    J Korean Med Sci; 2021 Apr; 36(15):e113. PubMed ID: 33876590
    [No Abstract]   [Full Text] [Related]  

  • 10. The COVID-19 pandemic: lifestyle and cardiovascular risk factors.
    Bhatnagar D
    Curr Opin Lipidol; 2021 Feb; 32(1):71-73. PubMed ID: 33315619
    [No Abstract]   [Full Text] [Related]  

  • 11. [COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].
    Pallarés-Carratalá V; Polo García J; Martín Rioboo E; Ruíz García A; Serrano-Cumplido A; Barrios V;
    Semergen; 2021; 47(1):1-3. PubMed ID: 33478841
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19.
    Parums DV
    Med Sci Monit; 2022 May; 28():e937048. PubMed ID: 35490309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in environmental noise during COVID-19 pandemic and cardiovascular disease: A mystery for further investigation.
    Antza C; Stabouli S
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1947-1948. PubMed ID: 32882108
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
    Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and cardiovascular risk: Flying toward a silent world?
    Dutheil F; Baker JS; Navel V
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1945-1946. PubMed ID: 32892458
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis and management of myocardial injury in coronavirus disease 2019.
    Wei ZY; Geng YJ; Huang J; Qian HY
    Eur J Heart Fail; 2020 Nov; 22(11):1994-2006. PubMed ID: 32683753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.
    Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J
    Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should COVID-19 be considered cardiovascular disease risk equivalent?
    Kow CS; Ramachandram DS; Hasan SS
    Int J Cardiol; 2023 Apr; 377():123. PubMed ID: 36724830
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?
    Xiaoliang Yan ; Jing L; Deng Y
    Heart Surg Forum; 2020 Nov; 23(6):E895-E896. PubMed ID: 33253109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular complications of COVID-19: toward better understanding, diagnosis, monitoring and management.
    Vicenzi M; Ruscica M; Jamialahmadi T; Sahebkar A
    Expert Rev Anti Infect Ther; 2022 Mar; 20(3):325-326. PubMed ID: 34343449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.